Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuhanting Granules in children with diaphoresis and recurrent respiratory tract infection
ChiCTR2200066001Phase 4Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2022
- Countries
- 1
01
Overview
Phase 4, open-label trial of Xuhanting in Airways Infection (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Efficacy for spontaneous sweating and night sweats, Efficacy of TCM symptoms and 7 more. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
Xuhanting
03
Conditions
Airways Infection
Beyond the preview
Go deeper on ChiCTR2200066001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066001.